GABA is a major inhibitory neurotransmitter in the CNS where it regula
tes neuronal excitability. These actions of GABA are mediated through
GABA receptor subtypes, one of which is the GABA(B) receptor (GBR). Th
e development of specific agonists and antagonists for GBRs has led to
a better understanding of their functional roles, which mainly focus
on the long-term modulation of neural activity. In this review, the au
thors emphasize the current knowledge of the structure-action profile
of compounds active at GBRs, characterizing their physiology and pharm
acology and highlighting their potential as targets for drug developme
nt.